Retrospective Analysis of Clinical Efficacy of Erlotinib in Patients with Non-Small Cell Lung Cancer

Nicola Pratesi, Francesco Di Costanzo, Lisa Simi, Camilla Eva Comin, Cristina Maddau, Claudio Orlando, Virginia Rotella, Luca Boni, Francesca Mazzoni, From clinical trials to clinical practice: predictors of response to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy. Tumori. ,vol. 97, pp. 160- 165 ,(2011) , 10.1700/667.7777

Hiroki Nagai, Shiro Tanaka, Miyuki Niimi, Nanae Seo, Takahiko Sasaki, Hiroshi Date, Michiaki Mishima, Hiroyasu Yasuda, Kazuhiro Yanagihara, None, Safety of erlotinib treatment in outpatients with previously treated non-small-cell lung cancer in Japan International Journal of Clinical Oncology. ,vol. 16, pp. 560- 567 ,(2011) , 10.1007/S10147-011-0228-0

Soley Bayraktar, Molecularly targeted therapies for advanced or metastatic non-small-cell lung carcinoma World journal of clinical oncology. ,vol. 4, pp. 29- 42 ,(2013) , 10.5306/WJCO.V4.I2.29

Patrick M Forde, David S Ettinger, Targeted therapy for non-small-cell lung cancer: Past, present and future Expert Review of Anticancer Therapy. ,vol. 13, pp. 745- 758 ,(2013) , 10.1586/ERA.13.47

Adnan Aydiner, Ibrahim Yildiz, Avesta Seyidova, Clinical outcomes and prognostic factors associated with the response to erlotinib in non-small-cell lung cancer patients with unknown EGFR mutational status. Asian Pacific Journal of Cancer Prevention. ,vol. 14, pp. 3255- 3261 ,(2013) , 10.7314/APJCP.2013.14.5.3255

Maria Anna Bareschino, Valentina Barbato, Cesare Gridelli, Paolo Maione, Paola Claudia Sacco, Rita Ambrosio, Clorinda Schettino, Marzia Falanga, Antonio Rossi, Erlotinib in the Treatment of Non-small Cell Lung Cancer: Current Status and Future Developments Anticancer Research. ,vol. 30, pp. 1301- 1310 ,(2010)

Halit Karaca, Efficacy and Safety of Erlotinib in Previously Treated Advanced Non-Small Cell Lung Cancer International Journal of Hematology and Oncology. ,vol. 23, pp. 1- 6 ,(2013) , 10.4999/UHOD.12009